Results 101 to 110 of about 4,420 (152)

Reduced Circulating Angiopoietin-Like Protein Levels in Crimean-Congo Hemorrhagic Fever. [PDF]

APMIS
Yeşildağ S, Büyüktuna SA, Öksüz C, Doğan HO.   +3 more
europepmc   +1 more source

Is FH a curable disease? [PDF]

Glob Cardiol Sci Pract
Seidah NG.
europepmc   +1 more source

Key Hepatokines Linking MASLD and Type 2 Diabetes: From Pathophysiological Mechanisms to Therapeutic Modulation. [PDF]

Int J Mol Sci
Foia GL, Goriuc A, Luchian I, Budala DG, Toma V, Bogdan M, Minea B, Ghemiș L.   +7 more
europepmc   +1 more source

Common Single Nucleotide Polymorphisms in Clinical Cardiology and Dietary Intervention: A Narrative Review. [PDF]

Nutrients
Hands JM, Blain K, Swidan S, Frame LA.
europepmc   +1 more source

Unraveling the physiological impact of ANGPTL8 loss-of-function variants in humans. [PDF]

Sci Rep
Abadi A, Chen YQ, Khalid S, Williams K, Zhen EY, Li H, Siegel R, Hartley M, Beyer TP, DeBowles D, Qian YW, Rahseed A, Khan MZ, Jahanzaib M, Mian MR, Sultana R, Jalal A, Abbas S, Muddassir A, Mohsin SN, Mukhtar S, Mahmood A, Ryan TP, Michael LF, Ruotolo G, Saleheen D, Wen Y, Konrad RJ, Bhatnagar P.   +28 more
europepmc   +1 more source

Triglyceride-Rich Lipoproteins and ASCVD: Evidence for Causality and Challenges in Therapeutic Translation. [PDF]

Curr Atheroscler Rep
Björnson E, Adiels M.
europepmc   +1 more source

<i>ANGPTL3</i> Gene Editing: Promise and Prudence. [PDF]

Eur Cardiol
Lorenzatti AJ.
europepmc   +1 more source

CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia. [PDF]

Signal Transduct Target Ther
Mondal A, Misra A.
europepmc   +1 more source

RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside. [PDF]

Research (Wash D C)
Ali I, Qiu J, Cheang WS, Wang G, Xu S.
europepmc   +1 more source

Emerging Nucleic Acid-Based Therapies for Hypercholesterolemia with Focus on a New Modality, Liver-Directed miR-30c Analog C2. [PDF]

Cells
Srivastava RAK.
europepmc   +1 more source